Methods for enriching breast tumor cells

Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

210781, 210782, 435 2, 435 721, 435 724, 435803, 436514, 436518, 436527, 436824, 422 72, 422101, 422102, G01N 33574, B01L 1100

Patent

active

056482230

ABSTRACT:
The present invention relates to methods of enriching breast tumor cells from a patient's body fluids. In particular, it relates to the use of a cell-trap centrifugation tube containing a specific density gradient solution adjusted to a specific density to enrich for breast tumor cells from a cell mixture. The tube allows the desired cell population to be collected by decantation after centrifugation to minimize cell loss and maximize efficiency. In addition, the method can be further simplified by density-adjusted cell sorting which uses cell type-specific binding agents such as antibodies and lectins linked to carrier particles to impart a different density to the non-tumor or tumor cell populations allowing the breast tumor cells to be separated from the non-tumor cells in a more convenient manner. The rapid breast tumor cell enrichment method described herein has a wide range of applications, including but not limited to, detection of tumor cells by molecular and immunochemical means, and purging of tumor cells from an autologous bone marrow cell preparation prior to re-infusion.

REFERENCES:
patent: 3441205 (1969-04-01), Young, Jr.
patent: 3513976 (1970-05-01), James
patent: 3706305 (1972-12-01), Berger et al.
patent: 3706306 (1972-12-01), Berger et al.
patent: 3750645 (1973-08-01), Bennett et al.
patent: 3849072 (1974-11-01), Ayres
patent: 3862303 (1975-01-01), Anderson
patent: 3937211 (1976-02-01), Merten
patent: 3957654 (1976-05-01), Ayres
patent: 3957741 (1976-05-01), Rembaum et al.
patent: 3965889 (1976-06-01), Sachs
patent: 3985122 (1976-10-01), Topham
patent: 4001122 (1977-01-01), Griffin
patent: 4020831 (1977-05-01), Adler
patent: 4022576 (1977-05-01), Parker
patent: 4035316 (1977-07-01), Yen et al.
patent: 4040959 (1977-08-01), Berman et al.
patent: 4055501 (1977-10-01), Cornell
patent: 4066414 (1978-01-01), Selby
patent: 4105598 (1978-08-01), Yen et al.
patent: 4112924 (1978-09-01), Ferrara et al.
patent: 4134512 (1979-01-01), Nugent
patent: 4147628 (1979-04-01), Bennett et al.
patent: 4152270 (1979-05-01), Cornell
patent: 4181700 (1980-01-01), Chervenka
patent: 4203840 (1980-05-01), Stoeppler
patent: 4213456 (1980-07-01), Bottger
patent: 4256120 (1981-03-01), Finley
patent: 4378812 (1983-04-01), Sarstedt
patent: 4443345 (1984-04-01), Wells
patent: 4459997 (1984-07-01), Sarstedt
patent: 4510244 (1985-04-01), Parks et al.
patent: 4511349 (1985-04-01), Nielsen et al.
patent: 4511662 (1985-04-01), Baran et al.
patent: 4533468 (1985-08-01), Ensor et al.
patent: 4562844 (1986-01-01), Carpenter et al.
patent: 4569764 (1986-02-01), Satchell
patent: 4610846 (1986-09-01), Martin
patent: 4707276 (1987-11-01), Dodge et al.
patent: 4710472 (1987-12-01), Saur et al.
patent: 4777145 (1988-10-01), Luotola et al.
patent: 4824560 (1989-04-01), Alspector
patent: 4828716 (1989-05-01), McEwen et al.
patent: 4844818 (1989-07-01), Smith
patent: 4886071 (1989-12-01), Mehl et al.
patent: 4917801 (1990-04-01), Luderer et al.
patent: 4927749 (1990-05-01), Dorn
patent: 4927750 (1990-05-01), Dorn
patent: 4954264 (1990-09-01), Smith
patent: 4957638 (1990-09-01), Smith
patent: 4983369 (1991-01-01), Barder et al.
patent: 5030341 (1991-07-01), McEwen et al.
patent: 5030559 (1991-07-01), Nicolson et al.
patent: 5039401 (1991-08-01), Columbus et al.
patent: 5045201 (1991-09-01), Dubois et al.
patent: 5053134 (1991-10-01), Luderer et al.
patent: 5132232 (1992-07-01), Parker
patent: 5236604 (1993-08-01), Fiehler
patent: 5248480 (1993-09-01), Greenfield et al.
patent: 5260186 (1993-11-01), Cercek et al.
patent: 5269927 (1993-12-01), Fiehler
patent: 5271852 (1993-12-01), Luoma, II
patent: 5279936 (1994-01-01), Vorpahl
patent: 5308506 (1994-05-01), McEwen
patent: 5314074 (1994-05-01), Inbar
patent: 5474687 (1995-12-01), Van Vlasselaer
Blanchard et al., "Infiltration of Interleukin-2-inducible Killer Cells in Ascitic Fluid and Pleural Effusions of Advanced Cancer Patients," Cancer Research, vol. 48, pp. 6321-6327, (1988).
Wallach et al., "Affinity Density Perturbation: A New Fractionation Principle and Its Illustration in a Membrane Separation," FEBS Letters, vol. 21, No. 1, pp. 29-33, (1972).
"The CD System," Dako, Inc., (1990).
Dicke et al., 1968, "The Selective Elimination of Immunologically Competent Cells From Bone Marrow and Lymphatic Cell Mixtures," Transplantation 6(4):562-570.
Dicke et al., 1970, "Avoidance of Acute Secondary Disease by Purification of Hemopoietic Stem Cells with Density Gradient Centrifugation," Exp. Hematol. 20:126-130.
Dicke et al., 1971, "Allogeneic Bone Marrow Transplantation After Elimination of Immunocompetent Cells by Means of Density Gradient Centrifugation," Transplantation Proceedings 3(1):666-668.
Dicke et al., 1973, "The Use of Stem Cell Concentrates As Bone Marrow Grafts in Man," Transplantation Proceedings 5(1):909-912.
Korbling et al., 1977, "Procurement of Human Blood Stem Cells by Continuous-Flow Centrifugation--Further Comment," Blood 50:753-754.
Korbling et al., 1977, "In-Vitro and In-Vivo Properties of Canine Blood Mononuclear Leukocytes Separated by Discontinuous Albumin Density Gradient Centrifugation," Biomedicine 26:275-283.
Herzenberg et al., 1979, "Fetal Cells in the Blood of Pregnant Women: Detection and Enrichment by Fluorescence-Activated Cell Sorting" Proc. Natl. Aca. Sci. USA 76: 1453-5.
Osborne et al., 1980 "The Value of Estrogen and Progesterone Receptors in the Treatment of Breast Cancer" Cancer 46(12):2884-8.
Westley et al., 1980 "An Estrogen-Induced Protein Secreted By Human-Breast Cancer-Cells In Culture" European Journal of Cell Biology 22(1):397.
Gerdes et al., 1983 "Production of a Mouse Monoclonal Antibody Reactive with a Human Nuclear" Current Biotech Abs.
Kufe et al., 1984, "Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant Versus Benign Breast Tumors" Hybridoma 3(3):223-32.
Bray et al., 1987 "Serum Levels and Biochemical Characteristics of Cancer-Associated Antigen CA-549, a Circulating Breast Cancer Marker " Cancer Res. 47(22):5853-60.
Shpall et al., 1991, "Immunomagnetic purging of breast cancer from bone marrow for autologous transplantation," Bone Marrow Transplantation 7:145-151.
Lebkowski et al., 1992, "Rapid Isolation Of Human CD34 Hematopoietic Stem Cells--Purging of Human Tumor Cells," Transplantation 53(5):1011-1019.
Olofsson et al., 1983, "Separation of Human Bone Marrow in Density Gradients of Polyvinylpyrrolia Coated Silica Gel (Percoll)," Second J. Pharmatol. 24:254-262.
Osborne et al., 1980, "The Value of Estrogen and Progesterone Receptorsin the Treatment of Breast Cancer" Cancer 46(12):2884-8.
Westley et al., 1980, "An Estrogen-Induced Protein Secreted By Human-Breast Cancer Cells in Culture" European Journal of Cell Biology 22(1):397.
Gerdes et al., 1983 "Production of a Mouse Monoclonal Antibody Reactive with a Human Nuclear" Current Biotech Abs.
Ellis et al., 1984, "The Use of Discontinuous Percoll Gradients to Separate Populations of Cells from Human Bone Marrow and Peripheral Blood," J. of Immunological Methods 66;9-16.
Kufe et al., 1984, "Differential Reactivity of a Novel Monoclonal Antibody (DF3) with Human Malignant Versus Benign Breast Tumors" Hybridoma 3(3):223-32.
Lasky et al., 1985, "Size and Density Characterization of Human Committed and Multipotent Hematopoietic Progenitors" Exp. Hematol. 13:680-4.
Martin et al., 1986, "Purification of Haemopoietic Progenitor Cells From Patients with Chronic Granulocytic Leukaemia Using Percoll Density Gradients and Elutriation" Brit. J. Haematol. 63:187-98.
Bray et al., 1987 "Serum Levels and Biochemical Characteristics of Cancer-Associated Antigen CA-549, a Circulating Breast Cancer Marker" Cancer Res 47(22):5853-60.
Bianchi et al., 1990, "Isolation of fetal DNA from nucleated erythrocytes in maternal blood," Proc Natl. Acad. Sci. USA 87:3279-3283.
Price et al., 1991, "Prenatal diagnosis with fetal cells isolated from maternal blood by multiparameter flow cytometry," Am. J. Obstet. Gynecol. 165(6, part 1):1731-1737.
Shpall et al., 1991, "Immunomagnetic purgin of breast cancer fom bone marrow for autologous transplantation," Bone Mar

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Methods for enriching breast tumor cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Methods for enriching breast tumor cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for enriching breast tumor cells will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1491684

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.